This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alcaide, F.
Right arrow Articles by Martin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alcaide, F.
Right arrow Articles by Martin, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Sep 1996, 2117-2120, Vol 40, No. 9
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients

F Alcaide, J Carratala, J Linares, F Gudiol and R Martin
Department of Microbiology, Hospital Princeps d'Espanya, Ciutot Sanitaria i Universitaria de Bellvitge, Barcelona, Spain.

From January 1988 to December 1994, 66 consecutive blood culture isolates of viridans group streptococci collected from febrile neutropenic cancer patients were tested for antimicrobial susceptibilities by the agar dilution method. The antibiotics studied were erythromycin, clarithromycin, roxithromycin, dirithromycin, azithromycin, josamycin, diacetyl-midecamycin, spiramycin, and quinupristin-dalfopristin. A total of 26 (39.4%) strains were resistant to erythromycin with an MIC range of 0.5 to > 128 micrograms/ml. The strains were classified into three groups according to their penicillin susceptibility: 42 (63.6%) were susceptible, 8 (12.1%) were intermediately resistant, and 16 (24.3%) were highly resistant. The percentages of erythromycin-resistant strains in each group were 23.8, 62.5, and 68.8%, respectively. Streptococcus mitis was the species most frequently isolated (83.3%) and showed the highest rates of penicillin (40%) and erythromycin (43.6%) resistance. MICs of all macrolide antibiotics tested and of quinupristin-dalfopristin were higher for penicillin-resistant strains than for penicillin-susceptible strains. All macrolide antibiotics tested had cross-resistance to erythromycin, which was not observed with quinupristin-dalfopristin. Our study shows a high rate of macrolide resistance among viridans group streptococci isolated from blood samples of neutropenic cancer patients, especially those infected with penicillin-resistant strains. These findings make macrolides unsuitable prophylactic agents against viridans group streptococcal bacteremia in this patient population.


This article has been cited by other articles:

  • Achour, W., Guenni, O., Malbruny, B., Canu, A., Leclercq, R., Ben Hassen, A. (2004). Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients. J Antimicrob Chemother 54: 117-121 [Abstract] [Full Text]  
  • Sweeney, L. C., Dave, J., Chambers, P. A., Heritage, J. (2004). Antibiotic resistance in general dental practice--a cause for concern?. J Antimicrob Chemother 53: 567-576 [Abstract] [Full Text]  
  • Seppala, H., Haanpera, M., Al-Juhaish, M., Jarvinen, H., Jalava, J., Huovinen, P. (2003). Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J Antimicrob Chemother 52: 636-644 [Abstract] [Full Text]  
  • Balsalobre, L., Ferrandiz, M. J., Linares, J., Tubau, F., de la Campa, A. G. (2003). Viridans Group Streptococci Are Donors in Horizontal Transfer of Topoisomerase IV Genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47: 2072-2081 [Abstract] [Full Text]  
  • Perez-Trallero, E., Vicente, D., Montes, M., Marimon, J. M., Pineiro, L. (2001). High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults. J Antimicrob Chemother 48: 225-229 [Abstract] [Full Text]  
  • Rodriguez-Avial, I., Rodriguez-Avial, C., Culebras, E., Benitez, A., Picazo, J. J. (2001). Distribution of mef(A) and erm(B) genes in macrolide-resistant blood isolates of viridans group streptococci. J Antimicrob Chemother 47: 727-728 [Full Text]  
  • Alcaide, F., Benítez, M. A., Carratalà, J., Gudiol, F., Liñares, J., Martín, R. (2001). In Vitro Activities of the New Ketolide HMR 3647 (Telithromycin) in Comparison with Those of Eight Other Antibiotics against Viridans Group Streptococci Isolated from Blood of Neutropenic Patients with Cancer. Antimicrob. Agents Chemother. 45: 624-626 [Abstract] [Full Text]  
  • Jones, R. N., Pfaller, M. A. (2000). Potencies of Newer Fluoroquinolones against Viridans Group Streptococci Isolated in 637 Cases of Bloodstream Infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): Beyond Canada!. Antimicrob. Agents Chemother. 44: 2922-2923 [Full Text]  
  • Ferrándiz, M. J., Fenoll, A., Liñares, J., De La Campa, A. G. (2000). Horizontal Transfer of parC and gyrA in Fluoroquinolone-Resistant Clinical Isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 840-847 [Abstract] [Full Text]  
  • Ferrándiz, M. J., Oteo, J., Aracil, B., Gómez-Garcés, J. L., De La Campa, A. G. (1999). Drug Efflux and parC Mutations Are Involved in Fluoroquinolone Resistance in Viridans Group Streptococci. Antimicrob. Agents Chemother. 43: 2520-2523 [Abstract] [Full Text]  
  • de Azavedo, J. C. S., Trpeski, L., Pong-Porter, S., Matsumura, S., The Canadian Bacterial Surveillance Network, , Low, D. E. (1999). In Vitro Activities of Fluoroquinolones against Antibiotic-Resistant Blood Culture Isolates of Viridans Group Streptococci from across Canada. Antimicrob. Agents Chemother. 43: 2299-2301 [Abstract] [Full Text]  
  • Arpin, C., Canron, M.-H., Maugein, J., Quentin, C. (1999). Incidence of mefA and mefE Genes in Viridans Group Streptococci. Antimicrob. Agents Chemother. 43: 2335-2336 [Full Text]  
  • Levitz, R. E. (1999). Prosthetic-Valve Endocarditis Caused by Penicillin-Resistant Streptococcus mitis. NEJM 340: 1843-1844 [Full Text]  
  • Wisplinghoff, H., Reinert, R. R., Cornely, O., Seifert, H. (1999). Molecular Relationships and Antimicrobial Susceptibilities of Viridans Group Streptococci Isolated from Blood of Neutropenic Cancer Patients. J. Clin. Microbiol. 37: 1876-1880 [Abstract] [Full Text]  
  • González, I., Georgiou, M., Alcaide, F., Balas, D., Liñares, J., de la Campa, A. G. (1998). Fluoroquinolone Resistance Mutations in the parC, parE, and gyrA Genes of Clinical Isolates of Viridans Group Streptococci. Antimicrob. Agents Chemother. 42: 2792-2798 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»